Adlai Nortye Group Ltd.

ANL·NasdaqGM·Healthcare
Compare
14.22−1.40 (−8.96%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close15.62
Open15.65
Day range13.9116.22
52-week range0.8817.25
Off day high−12.33%
Off 52-week high−17.57%
Volume415.70K
Avg. volume (3M)192.98K
Market cap915.74M
EPS (TTM)-0.6600
Forward P/E-48.32
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.11
Shares outstanding58.73M
Short interest7.56% of float
Earnings dateAug 8, 2025 (est.)
Analyst target29.50
Profit margin−124.77%

Against its peers

Compare in full ›
ANL ADAG ORIC RCUS AKTS SNDX
Market cap 915.74M 183.97M 1.22B 3.06B 964.44M 1.48B
P/E (TTM) — — — — — —
Forward P/E -48.3 -4.9 -7.1 -7.5 -8.1 -19.4
Price/book 4.3 2.1 3.2 6.7 2.0 97.9
Dividend yield — — — — — —
1-year change +746.43% +48.91% −13.80% +46.69% −22.59% +11.78%
Today −8.96% −0.72% −1.50% −0.29% −4.46% −2.59%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ANL news ›
Seeking Alpha·Positive

Adlai Nortye Group: Only For The Risk-Tolerant After A Massive Rally

Adlai Nortye Group has surged ~1,600% since Dec. 2025, fueled by private placements and preclinical data for its pan-RAS[ON] inhibitor AN9025. Learn more about ANL stock here. - Adlai Nortye Group has surged ~1,600% since Dec. 2025, fueled…

Markets Daily·Negative

Adlai Nortye (NASDAQ:ANL) Director Sells $159,900.00 in Stock

Posted by Kim Johansen on Oct 1st, 2026 Ping Ji also recently made the following trade(s): Read Our Latest Research Report on ANL Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative therapies…

From articles in the 4Search news index.

In the news

4mentions in 30 days
4with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.